Apple to halt sales of Series 9, Ultra 2 version of watches in US over patent dispute
Apple users alert! Govt. warns against THIS critical risk Apple plans to suspend sales of the Series 9 and Ultra 2 versions of its popular watch for online US customers beginning on Thursday afternoon and in its stores on Sunday.
The move stems from an October decision by the International Trade Commission restricting Apple's watches with the Blood Oxygen measurement feature as part of an intellectual property dispute with medical technology company Masimo. Apple may revert to THIS iPhone 12 design with upcoming iPhone 16 The White House had 60 days to review the ITC order issued on October 26, meaning Apple could have kept selling the two affected models in the US through Christmas.
But the Cupertino, California, company said in a Monday statement that it is pausing sales early to ensure it complies with the ITC order. If the ITC's sales ban isn't overturned, Apple pledged to “take all measures" to resume sales of the Series 9 and Ultra 2 models in the US as soon as possible.
Top Amazon year-end deals on smartphones: Apple iPhone 13, OnePlus 11R 5G, more The Apple Watch SE, which lacks the Blood Oxygen feature, will remain on sale in the US after Christmas Eve. Previously purchased Apple Watches equipped with the Blood Oxygen aren't affected by the ITC order.Milestone Alert!
Livemint tops charts as the fastest growing news website in the world
